Keratinocyte Skin Cancer Surgery in the Elderly, Aged 80 Years and Over, is Effective and Safe

NCT06665581 | Completed

• 1 other identifier: GerSurg
• Study Type: observational
• Target: 345
• Locations: 1 country
• Sites: 2

Brief Summary

As a result of a longer life expectancy and a change in UV exposure, physicians will be facing a growing number of elderly patients with keratinocyte cancer (KC) in fair-skinned populations. The purpose of this study is to better characterize KC surgery in patients over 80 years and older with different comorbid conditions and to investigate the incidence of complications associated with KC surgery. A retrospective monocentric study of patients aged 80 and older, having surgery for KC in University Hospital of Zurich between January 1, 2022, and December 31, 2022, was conducted. Demographics, comorbidities, current medication, treatment type, tumor characteristics, surgical defect size, repair type and complications within 6 months after surgery were analyzed.

Conditions

Postoperative Complication

Outcome Measures

Primary Outcomes (1)

• Incidence of complications associated with KC surgery in individuals aged 80 years and older

  From January 1, 2022, to December 31, 2022

Eligibility Criteria

• Age: 80 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged 80 and older having surgery for KC in University Hospital of Zurich between January 1, 2022, and December 31, 2022. All patients included in the study were operated on by the same dermatologic surgery team of University Hospital of Zurich under local anesthe-sia

You may qualify if:

• Patients aged 80 and older, having surgery for KC in University Hospital of Zurich between January 1, 2022, and December 31, 2022

You may not qualify if:

• Presence of a documented rejection.

Sponsors & Collaborators

• Juerg Hafner: lead

Study Sites (2)

University Hospital Zurich, Dermatology Clinic

Zurich, Canton of Zurich, 8091, Switzerland

Location

University Hospital Zurich

Zurich, Canton of Zurich, 8091, Switzerland

Location

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: University Hospital Zurich

Study Record Dates

• First Submitted: October 29, 2024
• First Posted: October 30, 2024
• Study Start: January 1, 2022
• Primary Completion: August 1, 2023
• Study Completion: August 1, 2024
• Last Updated: October 30, 2024

Record last verified: 2024-10

Locations

CH (2)